ACTRN12620000207910尚未招募4 期
PRevention of Opioid-associated constipation in Ventilated INtensive CarE patients (PROVINCE) Study: A randomised controlled trial of enterally-administered naloxone for the prevention of opioid-associated constipation in ventilated intensive care patients.
Dr Eamon Raith0 个研究点目标入组 300 人开始时间: 2020年2月20日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Age greater than or equal to 18 years.
- •-Receiving opiates.
- •-Mechanically ventilated.
- •-Suitable for or receiving enteral nutrition.
- •-Likely to stay in the ICU for at least 72h
排除标准
- •-Age <18 years.
- •-Contraindications to the use of enteral naloxone/oxycodone combination.
- •-Have a colostomy
- •-Bowel obstruction
研究者
相似试验
招募中
4 期
*Prevention of opioid-induced constipation in patients with advanced cancer*10018012constipationNL-OMON53756Amsterdam UMC330
招募中
Unknown
Observational study on opioid-induced constipation in patients with non-cancer chronic pain using weak opioid analgesics in JapaOpioid Induced ConstipationJPRN-UMIN000050203Shionogi & Co., Ltd.60
招募中
1 期
Prevention of opioid-induced constipation in patients with advanced cancerOpioid-induced constipation in patients with advanced cancer, starting with opioids for painMedDRA version: 24.0Level: LLTClassification code 10071128Term: Opioid induced constipationSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2022-000408-36-NLZonMw330
进行中（未招募）
不适用
Prevention of constipation during treatment with opioids: magnesiumoxide versus macrogol/elektrolytesEUCTR2007-007610-10-NLMC Utrecht
已完成
3 期
Prevention of constipation during treatment with opioids: magnesiumoxide versus macrogol/elektrolytesConstipation/difficulty with bowel movements10017977NL-OMON33671niversitair Medisch Centrum Utrecht155